Mr. Johnson has substantial experience in the merger and acquisition area, especially in the life sciences and technology spaces representing both buyers and sellers. He represented Covidien in its acquisition of Somanetics Corporation, Ansys, Inc. in connection with its acquisitions of Apache Design Solutions, Inc., Fluent, Inc. and Ansoft Corporation, CPEX Pharmaceutical in its sale to Footstar, Inc. and CombinatoRX Incorporated in its acquisition of Neuromed Pharmaceuticals Inc. He also represented Global Imaging Systems, Inc. in connection with its sale to Xerox.
Mr. Johnson frequently advises investment funds and institutional investors, such as Highfields Capital Management and Abrams Capital, concerning their investments in public and private issuers and with respect to issues in the corporate governance area. In particular, he has represented Highfields in connection with its investments in Clear Channel, Corelogic, First American Corporation, Circuit City and Morgan Stanley, and Abrams in connection with its activities with Juno Lighting and USA Mobility.
Mr. Johnson also represents companies in connection with proxy contests and issues in the corporate governance area. He has recently represented Arbinet Corporation, CPEX Pharmaceuticals, CombinatoRx, Enzenia!, Mac-Gray Corporation, and Repligen in connection with such matters.
Mr. Johnson has been selected for inclusion in Chambers USA: America’s Leading Lawyers for Business, The Best Lawyers in America and Massachusetts Super Lawyers 2011.
J.D., Boston College Law School (summa cum laude), 1986
B.A.,Vassar College (cum laude), 1983